+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Sweden

  • ID: 4861667
  • Report
  • September 2019
  • Region: Global, Sweden
  • 96 Pages
  • FinGlobe, Inc
1 of 3

FEATURED COMPANIES

  • 2cureX AB
  • BioGaia AB
  • C-Rad AB
  • Intervacc AB
  • Orexo AB
  • Scandinavian ChemoTech AB
  • MORE
This trends report provides comprehensive analysis on all licensing deals and negotiations reported for the healthcare companies of Sweden during January 1, 2019 to August 31, 2019, categorized and summarized by various important aspects such as healthcare sub-sectors, market capitalization groups, medicine groups, across key regions, licensing payment arrangements, and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segments of Sweden.

Analytical data coverage:
  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 150+ healthcare licensing news of 90+ companies of Sweden
  • Small-mid-large cap companies covered-LargeCap (4%), SmallCap (19%), MidCap (8%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered-Pharmaceuticals (26%), Biotech (29%), Medical Devices (35%), Healthcare Services (10%)
  • 14 medicine groups studied-Oncology (31%), Radiation Oncology (9%), Neurology (8%)
  • 8+ variables analyzed
Key Features:
  • 8 months’ healthcare licensing transactions of Sweden analyzed at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized
The Report is useful to:
  • Healthcare companies of Sweden planning to introduce products in other countries
  • Companies active in R&D and seeking new market base
  • Healthcare company executives of Sweden negotiating licensing deals
  • Investors analyzing varied kinds of transaction options for licensing deals in Sweden
Key analysis provided: January-August 2019
  • Total number of licensing deals signed by companies of Sweden
  • Total number of companies/institutes of Sweden involved in the licensing deals
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • 2cureX AB
  • BioGaia AB
  • C-Rad AB
  • Intervacc AB
  • Orexo AB
  • Scandinavian ChemoTech AB
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions of Sweden licensed during last eight months
1.1 Healthcare sub-sectors with most licensing deals
1.2 Market capitalization groups with most licensing deals
1.3 Medicine groups most active in licensing deals
1.4 Licensing payment arrangements most followed
1.5 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals of Sweden by key attributes during last eight months
2.1 For each of the healthcare sub-sectors
2.2 For each of the marketcap groups
2.3 For each of the medicine groups
2.4 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed for Sweden during last eight months - By company name
Appendix 2 List of companies/institutes covered - By company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By company name
Appendix 6 List of not-for-profit groups covered - By institute name
Appendix 7 List of companies/institutes covered - By medicine group and company name
Appendix 8 List of companies/institutes covered - By terms of payment and company name
Appendix 9 Licensing deals discontinued for Sweden during last eight months
Note: Product cover images may vary from those shown
3 of 3
  • 2cureX AB
  • ADDvise Group AB
  • Affibody AB
  • Alligator Bioscience AB
  • Anthrop Pharmaceuticals AB
  • Apoteket AB
  • Aptahem AB
  • Arcoma AB
  • AroCell AB
  • Attana AB
  • Bactiguard AB
  • Beactica AB
  • Belina Pharma AB
  • BioArctic AB
  • BioGaia AB
  • BioInvent International AB
  • Bioservo Technologies AB
  • Biotage AB
  • Biovica International AB
  • BoneSupport AB
  • Calliditas Therapeutics AB
  • Camanio Care AB
  • Camurus AB
  • Cantargia AB
  • Cartana AB
  • CBD Solutions AB
  • CCS Healthcare AB
  • Cellink AB
  • Cereno Scientific AB
  • Clinical Laserthermia Systems AB
  • C-Rad AB
  • Diaverum AB
  • Dignitana AB
  • Double Bond Pharmaceutical International AB
  • Elekta AB
  • Elekta Instrument AB
  • Elos Medtech AB
  • Emeriti Bio AB
  • Episurf Medical AB
  • Genagon Therapeutics AB
  • Genovis AB
  • Iconovo AB
  • Immunovia AB
  • Infant Bacterial Therapeutics AB
  • Inhalation Sciences Sweden AB
  • Integrum AB
  • Intervacc AB
  • Invent Medic Sweden AB
  • IRRAS AB
  • Karolinska Institutet
  • Karolinska University Hospital
  • Klaria Pharma Holding AB
  • Lidds AB
  • Lipum AB
  • Lokon Pharma AB
  • Mentice AB
  • Moberg Pharma AB
  • Molnlycke Health Care AB
  • Nanologica AB
  • NeuroVive Pharmaceutical AB
  • ObsteCare AB
  • Orexo AB
  • Ortoma AB
  • Paxman AB
  • Peptonic Medical AB
  • Perimed AB
  • Pharmacolog AB
  • Phase Holographic Imaging PHI AB
  • Pilloxa AB
  • PledPharma AB
  • POA Pharma Scandinavia AB
  • Promimic AB
  • RaySearch Laboratories AB
  • Redsense Medical AB
  • Sahlgrenska University Hospital
  • Sandoz Nordics
  • Scandinavian ChemoTech AB
  • Sectra AB
  • Sedana Medical AB
  • SenzaGen AB
  • Senzime AB
  • Skandionkliniken
  • Sprint Bioscience AB
  • Swedish Orphan Biovitrum AB
  • Swedish University of Agricultural Sciences
  • SyntheticMR AB
  • Tataa Biocenter AB
  • Teva Sweden AB
  • Trimb Healthcare AB
  • Umeå University
  • Uppsala University
  • Uppsala University Hospital
  • VibroSense Dynamics AB
  • Vingmed Holding A/S
  • Vitrolife AB
  • Xbrane Biopharma AB
  • Xvivo Perfusion AB (publ)
Note: Product cover images may vary from those shown
Adroll
adroll